FGFR2 and congenital adrenal hyperplasia: Additionally, we showed that inhibition of FGFR signaling was also able to lower aldosterone levels in our mouse model of βCat–driven adrenal hyperplasia (βCat-GOF) following genetic (Fgfr2 deletion) and pharmacological approaches.